Guo et al. showed that downregulation of IL-4R led to enhanced apoptosis, diminished proliferation, and reduced invasion of hepatocellular carcinoma cells, and abolished IL-4-induced activation of JAK/STAT6 and JNK/ERK1/2 signaling pathways [129]. The gene discussed is STAT6; the disease is hepatocellular carcinoma.